You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 20, 2024

~ Buy the CIPRODEX (ciprofloxacin; dexamethasone) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR CIPRODEX

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CIPRODEX

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00945802 ↗	FST-201 In The Treatment of Acute Otitis Externa	Terminated	Shire	Phase 3	2009-07-31	The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute otitis externa.
NCT00956748 ↗	N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media	Withdrawn	St. Paul's Hospital, Canada	Phase 4	2019-11-29	Chronic suppurative otitis media (CSOM) can be particularly difficult to treat as a number of patients do not respond to routine antibiotic or surgical treatments. The current treatment involves administering combination antibiotic anti-inflammatory ear drops such as Ciprodex (ciprofloxacin 0.3% / dexamethasone 0.1%). Although most patients experience a relief of symptoms, a fraction of patients remain refractory to treatment. Recent findings suggest that the addition of N-acetylcysteine (0.5-2%) to Ciprodex is a superior treatment for otitis media with effusion compared to the use of Ciprodex alone.
NCT00961675 ↗	FST-201 in the Treatment of Acute Otitis Externa	Completed	Shire	Phase 3	2009-08-31	The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This study will be conducted at one site, the Lyndon B. Johnson (LBJ) Tropical Medical Center, Department of Otolaryngology, in Pago Pago, American Samoa.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CIPRODEX

Condition Name

Chart
Table

Condition Name for CIPRODEX
Intervention	Trials
Acute Otitis Externa	3
Otorrhea	2
Acute Otitis Media	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CIPRODEX
Intervention	Trials
Otitis	9
Otitis Media	5
Otitis Externa	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CIPRODEX

Trials by Country

Map
Table

Trials by Country for CIPRODEX
Location	Trials
United States	51
Puerto Rico	2
Canada	1
Israel	1
American Samoa	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CIPRODEX
Location	Trials
Texas	4
Florida	4
Virginia	3
Oregon	3
Ohio	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CIPRODEX

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CIPRODEX
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	5
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CIPRODEX
Clinical Trial Phase	Trials
Completed	4
Terminated	4
Withdrawn	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CIPRODEX

Sponsor Name

Chart
Table

Sponsor Name for CIPRODEX
Sponsor	Trials
Shire	2
Alcon Research	2
Novum Pharmaceutical Research Services	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CIPRODEX
Sponsor	Trials
Industry	10
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.